Introduction Semaglutide, A medication that has taken the healthcare world by storm, is revolutionizing the treatment landscape for individuals with type 2 diabetes and obesity. Initially developed as a treatment for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class of drugs. By mimicking the natural hormone GLP-1, https://onlinecancerconsultation27036.webdesign96.com/32093110/semaglutide-a-breakthrough-in-managing-type-2-diabetes-obesity-and-heart-health